NCT01756755View on ClinicalTrials.gov

Endotoxin Adsorber Hemoperfusion and Microcirculation

NACompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

August 31, 2018

Study Completion Date

June 30, 2019

Conditions
Sepsis
Interventions
DEVICE

PMX-20R Hemoperfusion

Polymyxin B adsorbs and remove endotoxin from the patient's circulating blood.

Trial Locations (3)

100

National Taiwan University Hospital, Taipei

110

Taipei Medical University Hospital, Taipei

231

Taipei Tzu Chi General Hospital, New Taipei City

All Listed Sponsors
lead

National Taiwan University Hospital

OTHER

NCT01756755 - Endotoxin Adsorber Hemoperfusion and Microcirculation | Biotech Hunter | Biotech Hunter